Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture.

[1]  S. Nissen,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[2]  I. Raskin,et al.  Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  W. Cefalu,et al.  Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. , 2006, The Journal of nutrition.

[4]  M. Tremblay,et al.  Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer. , 2005, Biochimica et biophysica acta.

[5]  J. Gibson,et al.  Can Claims, Misleading Information, and Manufacturing Issues Regarding Dietary Supplements Be Improved in the United States? , 2005, Journal of Pharmacology and Experimental Therapeutics.

[6]  G. Bray,et al.  Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. , 2005, The Journal of clinical investigation.

[7]  S. Mudaliar,et al.  Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. , 2005, American journal of physiology. Endocrinology and metabolism.

[8]  C. Sutherland,et al.  Constitutive Activation of GSK3 Down-regulates Glycogen Synthase Abundance and Glycogen Deposition in Rat Skeletal Muscle Cells* , 2005, Journal of Biological Chemistry.

[9]  A. Bysar,et al.  Traditional dietary adjuncts for the treatment of diabetes mellitus , 2005 .

[10]  O. Ukkola,et al.  Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes , 2004, Journal of internal medicine.

[11]  M. Neuhouser.  Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs. , 2003, The Journal of nutrition.

[12]  W. Cefalu,et al.  Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. , 2002, The Journal of nutrition.

[13]  B. Goldstein.  Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  B. Goldstein,et al.  Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. , 2001, Current drug targets. Immune, endocrine and metabolic disorders.

[15]  L. Witters.  The blooming of the French lilac. , 2001, The Journal of clinical investigation.

[16]  Z. Zhang,et al.  Protein tyrosine phosphatases: prospects for therapeutics. , 2001, Current opinion in chemical biology.

[17]  B. Neel,et al.  Combinatorial control of the specificity of protein tyrosine phosphatases. , 2001, Current opinion in cell biology.

[18]  J. E. Bleasdale,et al.  Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors , 2001, Molecular and Cellular Endocrinology.

[19]  D. Barford,et al.  Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. , 2000, Molecular cell.

[20]  M. R. Calera,et al.  Dynamics of Protein-tyrosine Phosphatases in Rat Adipocytes* , 2000, The Journal of Biological Chemistry.

[21]  D S Lawrence,et al.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Cefalu,et al.  Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rats , 1997, Experimental Gerontology.

[23]  G. Dohm,et al.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.

[24]  J. Chernoff,et al.  Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin* , 1997, The Journal of Biological Chemistry.

[25]  R. Hanson,et al.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.

[26]  J. Olefsky,et al.  Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor , 1996, Diabetes.

[27]  M. Gómez-Lechón,et al.  A microassay for measuring glycogen in 96-well-cultured cells. , 1996, Analytical biochemistry.

[28]  S. Mudaliar,et al.  Acquired Defects of Glycogen Synthase Activity in Cultured Human Skeletal Muscle Cells: Influence of High Glucose and Insulin Levels , 1996, Diabetes.

[29]  S. Haffner,et al.  The Insulin Resistance Syndrome Revisited , 1996, Diabetes Care.

[30]  S. Mudaliar,et al.  Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. , 1995, The Journal of clinical investigation.

[31]  R. Henry,et al.  Insulin Action and Glucose Metabolism in Nondiabetic Control and NIDDM Subjects: Comparison Using Human Skeletal Muscle Cell Cultures , 1995, Diabetes.

[32]  F. Giorgino,et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. , 1995, The Journal of clinical investigation.

[33]  R. DeFronzo.  Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web , 1992, Journal of cardiovascular pharmacology.

[34]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[35]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.